Commentary

Article

State of the Science Summit - GU Cancers: Chaired by Mehmet Asim Bilen, MD, and Jacqueline T. Brown, MD

State of the Science Summit - GU Cancers: Chaired by Mehmet Asim Bilen, MD, and Jacqueline T. Brown, MD

State of the Science Summit - GU Cancers: Chaired by Mehmet Asim Bilen, MD, and Jacqueline T. Brown, MD

Speakers:

  • Bassel Nazha, MD, MPH | Winship Cancer Institute of Emory University
  • Jamie Goldman, MD | Winship Cancer Institute of Emory University
  • John French, MD | Northwest Georgia Oncology Centers
  • Bradley Carthon, MD, PhD | Winship Cancer Institute of Emory University
  • L. Crain Garrot, MD | Georgia Cancer Specialists

Topics

  • Navigating Combination Regimens for Front Line Advanced Clear-Cell RCC
  • Current and Emerging Treatments in Non-Clear Cell RCC and Subsequent Lines in Advanced Clear-Cell RCC
  • Clinical Scenarios: RCC
  • Front-Line Bladder Cancer Therapies
  • Sequencing in Bladder Cancer: Clinical Scenario Discussion
  • Targeted-Based Therapies for Metastatic and Non-Metastatic Prostate Cancers
  • Year in Review: Radioligand Therapy for Prostate Cancer

Interested in virtually attending an IPC event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science SummitsClick here to listen to our latest episodes!

Related Videos
Alexandra Drakaki, MD, PhD
Toni Choueiri, MD, director, Lank Center for Genitourinary Oncology, co-leader, kidney cancer program, Dana-Farber Cancer Institute; Jerome and Nancy Kohlberg Chair, professor, medicine, Harvard Medical School
Alexandra Drakaki, MD, PhD
Adam E. Singer, MD, PhD
Chad Tang MD, MD Anderson
Alexandra Drakaki, MD, PhD
Alexandra Drakaki, MD, PhD
Toni Choueiri, MD, director, Lank Center for Genitourinary Oncology, co-leader, kidney cancer program, Dana-Farber Cancer Institute; Jerome and Nancy Kohlberg Chair, professor, medicine, Harvard Medical School
Eric Jonasch, MD, professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
David A. Braun, MD, PhD